resveratrol/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on waist-to-hip ratio
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“The result indicated that there was just the trend of decrease but no significance after treatment with resveratrol compared with placebo in BW [SMD = − 0.08, 95% CI (−0.35, 0.18), p = 0.544], BMI [SMD = − 0.07, 95% CI (−0.33, 0.20), p = 0.633], WC [SMD = −0.73, 95% CI (−1.97, 0.51), p = 0.249] and WHR [SMD = −0.12, 95% CI (−0.40, 0.16), p = 0.405] (Supplementary Figures S14, 15).”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- meta-analysis
- Dose
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
- Population
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
Effect -0.12 standardised mean difference, 95% CI -0.4 to 0.16
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Waist-to-hip ratio
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3RM673HB5PNE67Z9BKBCJFH